CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 137 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,846,000 | +54.5% | 66,248 | +1.1% | 0.41% | +47.6% |
| Q4 2014 | $1,195,000 | +124.2% | 65,523 | +59.7% | 0.28% | +95.0% |
| Q3 2014 | $533,000 | -20.4% | 41,032 | 0.0% | 0.14% | -14.5% |
| Q2 2014 | $670,000 | -7.6% | 41,032 | 0.0% | 0.16% | -12.2% |
| Q1 2014 | $725,000 | -22.9% | 41,032 | +5.7% | 0.19% | -27.7% |
| Q4 2013 | $940,000 | -36.5% | 38,830 | -7.2% | 0.26% | -24.6% |
| Q3 2013 | $1,481,000 | – | 41,830 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TSP Capital Management Group, LLC | 813,273 | $3,286,000 | 1.66% |
| RTW INVESTMENTS, LP | 1,243,164 | $5,022,000 | 1.52% |
| Marcus Capital, LLC | 112,200 | $453,000 | 0.44% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 996,178 | $4,024,000 | 0.29% |
| Benchmark Capital Advisors | 67,000 | $271,000 | 0.20% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 360,299 | $1,456,000 | 0.20% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 2,907,523 | $11,746,000 | 0.15% |
| Virtus ETF Advisers LLC | 59,537 | $241,000 | 0.12% |
| Bellevue Group AG | 160,000 | $646,000 | 0.12% |
| PDT Partners, LLC | 428,300 | $1,730,000 | 0.10% |